Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy GoodRx stock in Canada | $50.14

Own GoodRx shares in just a few minutes.


Fact checked

GoodRx Holdings, Inc. is a health information services business based in the US. GoodRx shares (GDRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $50.14 – a decrease of 3.82% over the previous week. GoodRx employs 338 staff and has a trailing 12-month revenue of around $471.7 million.

How to buy shares in GoodRx

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: GDRX in this case.
  5. Research GoodRx shares. The platform should provide the latest information available.
  6. Buy your GoodRx shares. It's that simple.

GoodRx share price

Use our graph to track the performance of GDRX stocks over time.

GoodRx shares at a glance

Information last updated 2020-10-19.
Latest market close$50.14
52-week range$45.5 - $64.219
50-day moving average $52.9497
200-day moving average $52.9497
PE ratio 217.3396
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Compare online trading platforms

Name Product Available asset types Stock Fee Option Fee Account Fee ETF Transaction Cost
Wealthsimple Trade
Stocks, ETFs
Get a $25 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, IPOs, Precious Metals
$9.95 + $1 per contract
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Interactive Brokers
Stocks, Bonds, Options, Mutual Funds, ETFs, Currencies, Futures, Precious Metals
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0 (if monthly commissions are greater than or equal to US$10.00)
Min. $1.00, Max. 0.5% of trade value
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.

Compare up to 4 providers

Name Product Minimum deposit to invest Funding methods Management fee Available asset types
Wealthsimple Invest
Direct deposit, Bank transfer
0.40% - 0.50%
Stocks, Bonds, ETFs, Commodities
Get a $50 bonus when you open and fund your first Wealthsimple Invest account with a minimum initial deposit of at least $500. Trade and Cash accounts are not eligible.
CI Direct Investing (formerly WealthBar)
Direct deposit, Bank transfer
0.35% - 0.60%
Mutual Funds, ETFs
CI Direct Investing offers access to an exclusive and personalized investment portfolio. Get up to $10,000 managed free for a year when you sign up for your first CI Direct Investing account and fund your account.
Direct deposit, Bank transfer, Automatic bank withdrawals
Receive a cash bonus of $50.00-$225.00 when you open a new Justwealth account. RESP accounts require no minimum deposit to begin investing.
Automatic bank withdrawals
The Moka app rounds up every purchase you make to the nearest dollar and invests the spare change into low-cost exchange-traded funds (ETFs).

Compare up to 4 providers

Name Product Minimum Opening Deposit Commission Available Markets Platforms
Minimum US$25
Shares Desktop, Web Trading, Mobile Trading, MetaTrader 4
CFDs are leveraged products which involves greater risk than using cash resources only. You could lose all or more of your initial investment. Trade 80+ currency pairs and 220+ CFDs in equities, commodities and indices on

Compare up to 4 providers

Is it a good time to buy GoodRx stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

GoodRx price performance over time

Historical closes compared with the last close of $50.14

1 week (2021-01-15) 16.88%
1 month (2020-12-23) 5.36%
3 months (2020-10-23) -4.50%

Is GoodRx under- or over-valued?

Valuing GoodRx stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of GoodRx's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

GoodRx's P/E ratio

GoodRx's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 217x. In other words, GoodRx shares trade at around 217x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.


GoodRx's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$176.4 million.

The EBITDA is a measure of a GoodRx's overall financial performance and is widely used to measure a its profitability.

GoodRx financials

Revenue TTM USD$471.7 million
Operating margin TTM 34.23%
Gross profit TTM USD$374.2 million
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 18.98%
Book value N/A
Market capitalisation USD$19.9 billion

TTM: trailing 12 months

How to short and sell GoodRx shares

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "GDRX.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 1.9 million GoodRx shares held short by investors – that's known as GoodRx's "short interest". This figure is up from 0 last month.

There are a few different ways that this level of interest in shorting GoodRx shares can be evaluated.

GoodRx's "short interest ratio" (SIR)

GoodRx's "short interest ratio" (SIR) is the quantity of GoodRx shares currently shorted divided by the average quantity of GoodRx shares traded daily (recently around 8.7 million). GoodRx's SIR currently stands at 0.22. In other words for every 100,000 GoodRx shares traded daily on the market, roughly 220 shares are currently held short.

However GoodRx's short interest can also be evaluated against the total number of GoodRx shares, or, against the total number of tradable GoodRx shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case GoodRx's short interest could be expressed as 0% of the outstanding shares (for every 100,000 GoodRx shares in existence, roughly 0 shares are currently held short) or 0.0449% of the tradable shares (for every 100,000 tradable GoodRx shares, roughly 45 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against GoodRx.

Find out more about how you can short GoodRx stock.

GoodRx share dividends

We're not expecting GoodRx to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

GoodRx overview

GoodRx Holdings, Inc. is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Go to site